Impact of catechol-o-methyltransferase polymorphisms on risperidone treatment for schizophrenia and its potential clinical significance

Clinical Biochemistry
Shugui GaoMinfang Huang

Abstract

The main aim was to study the effects of COMT polymorphisms on response of risperidone treatment for schizophrenia and investigate the correlation between memory function of schizophrenia patients and COMT polymorphisms. Subjects were 83 schizophrenic patients who were antipsychotic drug free at the initiation of this study. Peripheral blood samples were obtained to identify COMT polymorphisms by using a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Clinical Global Impressions (CGI), Positive and Negative Syndrome Scale (PANSS) and Wechsler Memory Scale (WMS) test were used to assess the effect of risperidone treatment. The Val/Met carriers showed a significant increase in change of P300 during treatment (P=0.032). Association of Val/Met carriers performed better than other genotypes (P=0.028). The mean plasma concentration of prolactin of Val/Val carriers was significantly lower (P=0.017). The COMT polymorphisms may be a potential biomarker for clinical risperidone treatment in schizophrenia.

References

Jan 1, 1993·Schizophrenia Bulletin·J D Cohen, D Servan-Schreiber
Jan 1, 1997·Psychophysiology·J KatsanisS R Carlson
Jun 8, 2001·Proceedings of the National Academy of Sciences of the United States of America·M F EganD R Weinberger
Nov 12, 2003·The Pharmacogenomics Journal·Y YamanouchiN Ozaki
Dec 9, 2003·The Journal of Clinical Psychiatry·Robert L FindlingCarin Binder
Jan 28, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Michael N SmolkaAndreas Heinz
Jun 21, 2005·Journal of Psychiatric Research·Mao-Liang Chen, Chia-Hsiang Chen
Jul 11, 2006·Behavior Genetics·Mei Hua HallPak Sham
Apr 7, 2007·Schizophrenia Bulletin·Hywel J WilliamsMichael C O'Donovan
Mar 15, 2008·Biological Psychiatry·Jennifer H BarnettMarcus R Munafò
Jun 27, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Norio Yasui-FurukoriSunao Kaneko
Aug 30, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Francesco PapaleoJingshan Chen
Jul 17, 2009·The American Journal of Psychiatry·Jennifer H BarnettKe Xu
May 21, 2010·Nature Reviews. Neuroscience·Maria KarayiorgouJoseph A Gogos

❮ Previous
Next ❯

Citations

Dec 17, 2014·European Journal of Medical Genetics·Qi LiaoShiwei Duan
May 22, 2018·Journal of Attention Disorders·Johanna Inhyang KimBung-Nyun Kim
May 26, 2017·European Psychiatry : the Journal of the Association of European Psychiatrists·S GaoS Duan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here